Find a Physician | Courier | Events Calendar | About Us | Clinical Trials

Lurie Cancer Center Member

Sofia Garcia

Sofia F Garcia, PhD

Academic Title:
Assistant Professor, Medical Social Sciences; Feinberg School of Medicine

Member of:
Cancer Control (CCS)


View Publications Listing

Cancer-Focused Research:

Sofia Garcia, Ph.D. is an Assistant Professor in the Departments of Medical Social Sciences, and Psychiatry and Behavioral Sciences, at Northwestern University, and a licensed clinical psychologist. She is Director of Translational Research in the Cancer Survivorship Institute of the Robert H. Lurie Comprehensive Cancer Center (RHLCCC). Dr. Garcia has over ten years of research experience in patient-reported outcome measure development and applications in oncology. Her research has focused on developing and validating patient reported outcome measures and evaluating patient-centered care initiatives, including those that incorporate health information technology and are tailored to vulnerable populations. She has served as principal investigator of five, and scientific project director of four, cancer control and survivorship studies. Dr. Garcia has been scientific project director, mentored investigator and site principal investigator on three Patient Reported Outcomes Measurement Information System (PROMIS) supplement awards. She has also served as a co-investigator on numerous federally-funded studies, including those addressing health literacy and health disparities. Dr. Garcia’s ongoing research includes: evaluations of breast cancer survivorship care plans in both a comprehensive cancer center and a safety net hospital, an examination of the relationships between psychosocial risk factors and pro-inflammatory and pro-angiogenic cytokines in colorectal cancer, an investigation of the impact of treatment costs and financial counseling on cancer patients’ distress and quality of life, and an evaluation of a patient-facing symptom report in oncology care. In her clinical role, she provides psychological treatment and evaluation through the Supportive Oncology Program of the RHLCCC.

Related News